NCT00814268View on ClinicalTrials.gov

COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke

PHASE4CompletedINTERVENTIONAL
Enrollment

358

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Stroke
Interventions
DRUG

Clopidogrel

75mg tablet, oral administration once daily

DRUG

Clopidogrel placebo

Matching tablet, oral administration once daily

DRUG

Aspirin

100mg tablet, oral administration once daily

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Seoul

Sponsors

Lead Sponsor

Sanofi

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Sanofi

INDUSTRY

NCT00814268 - COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke | Biotech Hunter | Biotech Hunter